Nuclear Medicine

Controversy clouds nuclear medicine bill

Radiology societies and patient advocates are at odds over a bill in the U.S. Congress.

May 1, 2025

ARRS: 'Neurotheranostics' may be new frontier for nuclear medicine

Advances in brain PET imaging combined with new treatments for Alzheimer’s have given rise to a new concept of "neurotheranostics."

April 29, 2025

A conceptual framework for neurotheranostics.

ARRS: Rib uptake evaluation on F-18 DCFPyL PET/CT presents challenges

By Maryam Payne

Evaluating increased rib uptake on F-18 DCFPyL PET/CT in prostate cancer patients may lead to false positives.

April 28, 2025

Eckert & Ziegler signs manufacturing deal with Pentixapharm

By AuntMinnie.com staff writers

Eckert & Ziegler Radiopharma GmbH has signed a manufacturing agreement with Pentixapharm.

April 24, 2025

Manufacturing Facility Process

UM launches new research reactor with $10M deal

By AuntMinnie.com staff writers

The University of Missouri (UM) has inked a $10 million deal with a Korean consortium.

April 23, 2025

Shine Technologies, Modawina Medical sign UAE distribution deal

By AuntMinnie.com staff writers

Shine Technologies has signed an agreement with Modawina Medical Company to distribute Shine’s lutetium-177 isotope in the UAE.

April 22, 2025

Atom Nuclear Lab 400

Having a father with Alzheimer's could mean higher risk of the disease

By Kate Madden Yee

Having a father with Alzheimer's may be tied to a greater spread of the tau protein in the brain, researchers have reported.

April 9, 2025

China limits exports of rare earth elements, targets CT x-ray tubes

By Erik L. Ridley

China's Ministry of Commerce has announced export controls for several rare earth elements and launched investigations of imported CT x-ray tubes.

April 4, 2025

IAEA touts radionuclide development activities

The IAEA has highlighted its worldwide activities to meet increasing demands for alpha-emitting radionuclides for use in Targeted Alpha Therapy.

March 18, 2025

Kidneys appear to tolerate Lu-177 treatments

Kidney-absorbed doses of lutetium-177 (Lu-177)-based treatments for prostate cancer and neuroendocrine tumors appear to be below toxicity thresholds.

December 19, 2024

African American men respond more favorably to Ra-223 therapy

African American men with metastatic castrate-resistant prostate cancer may respond more favorably than white men to treatment with radium-223.

December 17, 2024

Prostate Imaging

Intraarterial PRRT safe in patients with meningioma

Intraarterial peptide receptor radionuclide therapy (PRRT) is a safe and effective alternative to intravenous PRRT in patients with advanced meningioma.

October 28, 2024

2024 10 28 Meningioma Thumbnail

Page 1 of 437